Icon (ICLR) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $175.13, +3.65% vs the prior close of $168.97.
- Volume 795.80K shares, 1.0x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ICLR jumps 3.6% to $175.13. Closed at $175.13, +3.65% vs the prior close of $168.97. Day range $166.94–$177.20, opened at $170.20.
ICLR daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — ICLR jumps 3.6% to $175.13
- Closed at $175.13, +3.65% vs the prior close of $168.97. Day range $166.94–$177.20, opened at $170.20.
- Volume was 795.80K shares, 1.0x its 50-day average of 797.21K.
- Price is +4.7% vs its 50-day average ($167.21) and +20.1% vs its 200-day average ($145.79).
- 52-week range $66.57–$203.91; today's close sits at 79% of that range, 14.1% below the 52-week high.
Oct 14, 2026 — ICLR rises 2.8% to $168.97
- Closed at $168.97, +2.82% vs the prior close of $164.34. Day range $163.14–$170.32, opened at $163.54.
- Volume was 629.70K shares, 0.8x its 50-day average of 805.52K.
- Price is +1.2% vs its 50-day average ($166.98) and +15.9% vs its 200-day average ($145.83).
- 52-week range $66.57–$203.91; today's close sits at 75% of that range, 17.1% below the 52-week high.
Oct 13, 2026 — ICLR ends flat (-0.0%) to $164.34
- Closed at $164.34, -0.04% vs the prior close of $164.40. Day range $159.72–$166.17, opened at $164.54.
- Volume was 815.10K shares, 1.0x its 50-day average of 813.46K.
- Price is -1.4% vs its 50-day average ($166.73) and +12.6% vs its 200-day average ($145.90).
- 52-week range $66.57–$203.91; today's close sits at 71% of that range, 19.4% below the 52-week high.
Oct 12, 2026 — ICLR ends flat (+0.1%) to $164.40
- Closed at $164.40, +0.14% vs the prior close of $164.17. Day range $163.90–$169.83, opened at $165.14.
- Volume was 869.50K shares, 1.1x its 50-day average of 813.51K.
- Price is -1.3% vs its 50-day average ($166.62) and +12.6% vs its 200-day average ($145.99).
- 52-week range $66.57–$203.91; today's close sits at 71% of that range, 19.4% below the 52-week high.
Oct 9, 2026 — ICLR ends flat (-0.2%) to $164.17
- Closed at $164.17, -0.20% vs the prior close of $164.50. Day range $163.47–$169.85, opened at $167.04.
- Volume was 745.60K shares, 0.9x its 50-day average of 834.08K.
- Price is -1.5% vs its 50-day average ($166.60) and +12.4% vs its 200-day average ($146.09).
- 52-week range $66.57–$203.91; today's close sits at 71% of that range, 19.5% below the 52-week high.
Oct 8, 2026 — ICLR ends flat (+0.3%) to $164.50
- Closed at $164.50, +0.26% vs the prior close of $164.08. Day range $159.16–$164.95, opened at $161.62.
- Volume was 1.03M shares, 1.2x its 50-day average of 844.99K.
- Price is -1.3% vs its 50-day average ($166.63) and +12.5% vs its 200-day average ($146.16).
- 52-week range $66.57–$203.91; today's close sits at 71% of that range, 19.3% below the 52-week high.
- SEC filings that day: 6-K.
Oct 7, 2026 — ICLR rises 1.5% to $164.08
- Closed at $164.08, +1.48% vs the prior close of $161.69. Day range $157.38–$165.22, opened at $160.93.
- Volume was 776.20K shares, 0.9x its 50-day average of 865.28K.
- Price is -1.7% vs its 50-day average ($166.90) and +12.2% vs its 200-day average ($146.21).
- 52-week range $66.57–$203.91; today's close sits at 71% of that range, 19.5% below the 52-week high.
Oct 6, 2026 — ICLR slides 3.9% to $161.69
- Closed at $161.69, -3.94% vs the prior close of $168.33. Day range $161.14–$177.67, opened at $169.69.
- Volume was 984.00K shares, 1.1x its 50-day average of 861.16K.
- Price is -3.3% vs its 50-day average ($167.22) and +10.5% vs its 200-day average ($146.28).
- 52-week range $66.57–$203.91; today's close sits at 69% of that range, 20.7% below the 52-week high.
Oct 5, 2026 — ICLR jumps 3.9% to $168.33
- Closed at $168.33, +3.88% vs the prior close of $162.05. Day range $160.99–$168.76, opened at $161.07.
- Volume was 932.50K shares, 1.1x its 50-day average of 857.66K.
- Price is +0.6% vs its 50-day average ($167.37) and +15.0% vs its 200-day average ($146.37).
- 52-week range $66.57–$203.91; today's close sits at 74% of that range, 17.4% below the 52-week high.
Oct 2, 2026 — ICLR ends flat (+0.1%) to $162.05
- Closed at $162.05, +0.12% vs the prior close of $161.85. Day range $160.41–$163.43, opened at $161.85.
- Volume was 676.10K shares, 0.8x its 50-day average of 869.78K.
- Price is -3.1% vs its 50-day average ($167.31) and +10.7% vs its 200-day average ($146.44).
- 52-week range $66.57–$203.91; today's close sits at 70% of that range, 20.5% below the 52-week high.
ICLR latest news & SEC filings
Every SEC filing by or about ICLR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Climax John Dr converted options/RSUs into 5,005 shares at $125.74 (≈$629.33K) on Sep 16, 2026; now holds 7,092
- Climax John Dr sold 5,005 shares at $175.00 (≈$875.88K) on Sep 16, 2026; now holds 2,087
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Mccague Eugene Pacelli converted options/RSUs into 3,255 shares at $125.74 (≈$409.28K) on Sep 17, 2026; now holds 7,066
- Mccague Eugene Pacelli sold 3,255 shares at $175.00 (≈$569.62K) on Sep 17, 2026; now holds 3,811
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Murphy Ronan Martin converted options/RSUs into 5,005 shares at $125.74 (≈$629.33K) on Sep 17, 2026; now holds 8,852
- Murphy Ronan Martin sold 5,005 shares at $175.00 (≈$875.88K) on Sep 17, 2026; now holds 3,847
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 17, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 17, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 16, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 9, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 20, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 18, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 31, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade ICLR
- How much it moves: over the last 20 sessions the average daily move was 2.17% (largest 6.1%).
- Liquidity: about 971.21K shares (≈$170.09M) trade per day on average.
- 52-week position: $175.13 vs a range of $66.57–$203.91 (79% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Eugene Pacelli Mccague sold 3,255 shares on Sep 17, 2026.
- Latest filings: 6-K Oct 8, 2026; 6-K Sep 9, 2026; 6-K Aug 20, 2026.
- Listing: Nasdaq · industry: Services-Commercial Physical & Biological Research.
ICLR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 170.20 | 177.20 | 166.94 | 175.13 | 795.80K |
| Oct 14, 2026 | 163.54 | 170.32 | 163.14 | 168.97 | 629.70K |
| Oct 13, 2026 | 164.54 | 166.17 | 159.72 | 164.34 | 815.10K |
| Oct 12, 2026 | 165.14 | 169.83 | 163.90 | 164.40 | 869.50K |
| Oct 9, 2026 | 167.04 | 169.85 | 163.47 | 164.17 | 745.60K |
| Oct 8, 2026 | 161.62 | 164.95 | 159.16 | 164.50 | 1.03M |
| Oct 7, 2026 | 160.93 | 165.22 | 157.38 | 164.08 | 776.20K |
| Oct 6, 2026 | 169.69 | 177.67 | 161.14 | 161.69 | 984.00K |
| Oct 5, 2026 | 161.07 | 168.76 | 160.99 | 168.33 | 932.50K |
| Oct 2, 2026 | 161.85 | 163.43 | 160.41 | 162.05 | 676.10K |
| Oct 1, 2026 | 169.99 | 170.22 | 160.90 | 161.85 | 677.20K |
| Sep 30, 2026 | 167.98 | 170.40 | 165.24 | 169.99 | 851.10K |
| Sep 29, 2026 | 174.50 | 176.70 | 169.73 | 170.35 | 1.44M |
| Sep 28, 2026 | 171.13 | 175.87 | 169.38 | 175.57 | 1.34M |
| Sep 25, 2026 | 173.80 | 174.92 | 170.44 | 172.33 | 965.90K |
| Sep 24, 2026 | 163.79 | 175.00 | 163.79 | 173.90 | 1.62M |
| Sep 23, 2026 | 167.77 | 169.28 | 163.41 | 163.90 | 1.06M |
| Sep 22, 2026 | 170.55 | 172.04 | 167.11 | 167.11 | 1.06M |
| Sep 21, 2026 | 164.61 | 169.95 | 163.16 | 169.55 | 1.03M |
| Sep 18, 2026 | 169.50 | 169.50 | 162.59 | 164.11 | 1.12M |
About Icon
Icon (ICLR) is listed on the Nasdaq and classified by the SEC under “Services-Commercial Physical & Biological Research”. Its business address is in DUBLIN 18, Ireland. Fiscal year ends —. SEC CIK 1060955.
ICLR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Barry Edward Balfe | Chief Executive Officer | Aug 11, 2026 |
| John Dr Climax | Director | Sep 18, 2026 |
| Stephen A Cutler | Director | Mar 18, 2026 |
| Kevin Francis Egan | Director | Aug 12, 2026 |
| Jeffrey Thomas Elliott | Director | Aug 11, 2026 |
| Linda Grais | Director | Aug 12, 2026 |
| Eugene Pacelli Mccague | Director | Sep 18, 2026 |
| Ronan Martin Murphy | Director | Sep 18, 2026 |
| Ciaran Murray | Director | Aug 12, 2026 |
| Julie O'Neill | Director | Aug 12, 2026 |
| Anne Clem Whitaker | Director | Aug 12, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Barry Edward Balfe | Chief Executive Officer | Aug 11, 2026 |
| Nigel Bernard John Clerkin | Chief Financial Officer | Aug 12, 2026 |
| Emer Lyons | Chief Accounting Officer | Aug 12, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 17, 2026 | Eugene Pacelli Mccague | Sale | 3,255 | $175.00 |
| Sep 17, 2026 | Ronan Martin Murphy | Sale | 5,005 | $175.00 |
| Sep 16, 2026 | John Dr Climax | Sale | 5,005 | $175.00 |
| Aug 11, 2026 | Anne Clem Whitaker | Sale | 88 | $162.72 |
| Aug 11, 2026 | Anne Clem Whitaker | Sale | 96 | $163.77 |
| Aug 11, 2026 | Anne Clem Whitaker | Sale | 67 | $165.51 |
| Aug 11, 2026 | Anne Clem Whitaker | Sale | 590 | $164.47 |
| Aug 11, 2026 | Nigel Bernard John Clerkin | Sale | 180 | $165.51 |
| Aug 11, 2026 | Nigel Bernard John Clerkin | Sale | 1,591 | $164.47 |
| Aug 11, 2026 | Nigel Bernard John Clerkin | Sale | 237 | $162.72 |
| Aug 11, 2026 | Nigel Bernard John Clerkin | Sale | 259 | $163.77 |
| Aug 11, 2026 | Linda Grais | Sale | 87 | $162.72 |
| Aug 11, 2026 | Linda Grais | Sale | 590 | $164.47 |
| Aug 11, 2026 | Linda Grais | Sale | 67 | $165.51 |
| Aug 11, 2026 | Linda Grais | Sale | 97 | $163.77 |
ICLR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
ICLR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Services-Commercial Physical & Biological Research
Iqvia (IQV)Charles River Laboratories International (CRL)Medpace (MEDP)Incyte (INCY)Absci (ABSI)Maxcyte (MXCT)OmniAb (OABI)Nrc Health (NRC)bioAffinity Technologies (BIAF)OneMedNet (ONMD)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on ICLR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.